Free Trial

eFFECTOR Therapeutics (EFTRW) Competitors

eFFECTOR Therapeutics logo

EFTRW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

eFFECTOR Therapeutics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and eFFECTOR Therapeutics (NASDAQ:EFTRW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

In the previous week, 180 Life Sciences had 1 more articles in the media than eFFECTOR Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for eFFECTOR Therapeutics. 180 Life Sciences' average media sentiment score of 1.88 beat eFFECTOR Therapeutics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
eFFECTOR Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
eFFECTOR Therapeutics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
eFFECTOR TherapeuticsN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats eFFECTOR Therapeutics on 2 of the 2 factors compared between the two stocks.

Get eFFECTOR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EFTRW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EFTRW vs. The Competition

MetriceFFECTOR TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$149.65M$5.77B$9.79B
Dividend YieldN/A3.74%3.95%4.02%
P/E RatioN/A3.8431.2726.59
Price / SalesN/A4,175.84440.26156.12
Price / CashN/A13.1937.7359.36
Price / BookN/A71.2310.616.68
Net IncomeN/A-$90.99M$3.27B$265.59M

eFFECTOR Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EFTRW
eFFECTOR Therapeutics
N/AN/AN/AN/A$0.00N/A0.0010
ATNFW
180 Life Sciences
N/A$0.22
+10.1%
N/A+2,713.9%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.46
+2.4%
N/AN/A$0.00$110.87K0.0040Gap Up
ALVOW
Alvotech
N/A$1.18
+4.3%
N/A-55.5%$0.00$560.10M0.004Positive News
Gap Up
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/A+139.5%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-0.1%
N/AN/A$0.00$39.19M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-10.6%
N/A-95.8%$0.00$199.07M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.02
+18.4%
N/A-94.3%$0.00N/A0.008Gap Up

Related Companies and Tools


This page (NASDAQ:EFTRW) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners